Alvotech (ALVO) Cash & Equivalents (2020 - 2026)

Alvotech (ALVO) has reported Cash & Equivalents for 7 consecutive years, with $142.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 5.75% year-over-year to $142.8 million; the trailing twelve-month figure through Jun 2026 stood at $142.8 million (down 5.75% YoY), and the FY2025 full-year result was $172.4 million, up 235.15% from the prior year.
• Cash & Equivalents rose to $142.8 million in Q2 2026 per ALVO's latest filing, from $63.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $172.4 million in Q4 2025 and bottomed at $10.9 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $81.8 million across 5 years, with a median of $64.3 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents plunged 83.2% in 2023, then soared 1283.88% in 2025.
• Over 5 years, Cash & Equivalents stood at $66.4 million in 2022, then plunged by 83.2% to $11.2 million in 2023, then jumped by 360.95% to $51.4 million in 2024, then surged by 235.15% to $172.4 million in 2025, then decreased by 17.18% to $142.8 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $142.8 million, $63.8 million, and $172.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.